Proposed Changes to the Recommended use of Zoster Vaccines

Closed 7 Aug 2022

Opened 8 Jul 2022


The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders on proposed changes to the recommended use of Zoster vaccines for inclusion in the Australian Immunisation Handbook, with an intention to submit the recommendation to the National Health and Medical Research Council (NHMRC) for its approval under section 14A of the National Health and Medical Research Council Act 1992.

The draft recommendations and the rationale for the changes are outlined in the attached public consultation document (see below).

Submission instructions

This public consultation will be open for a period of 30 days and you are invited to make a submission on the draft recommendation by 11.59PM on Sunday 7 August 2022.

If you have any questions in relation to this consultation process please contact the ATAGI Secretariat via email at

Your contribution is greatly appreciated.

How do I make a submission?

To make a submission, please click on the ‘Online Survey’ link below and follow the instructions. Please ensure you provide the page and section to which each of your comments refer. The ATAGI will not accept:

  • Comments received after the consultation deadline (11.59PM on 7 August 2022);
  • Confidential information that you do not wish to make public; or
  • Comments which, in the opinion of the ATAGI, are incorrect or inappropriate.


  • Aboriginal and Torres Strait Islander People
  • Seniors
  • Men
  • Women
  • Carers and guardians
  • Families
  • Parents
  • Young people
  • Non-government organisations
  • State government agencies
  • Commonwealth agencies
  • Local governments
  • Health professionals
  • Health workforce
  • General public
  • Community groups
  • Businesses
  • Contracted Service Providers
  • BPRU staff
  • Graduates
  • Online and Publications staff
  • Secretariat
  • PCCD
  • Health staff
  • HPRG (TGA) Staff
  • Prescription medicines
  • Complementary medicines
  • Over-the-counter medicines
  • Medical Devices & IVDs
  • Biogicals
  • Other


  • Communicable diseases
  • Preventative health
  • Policy Development